Disease progression strikingly differs in research and real-world Parkinson's populations.
Beaulieu-Jones BK, Frau F, Bozzi S, Chandross KJ, Peterschmitt MJ, Cohen C, Coulovrat C, Kumar D, Kruger MJ, Lipnick SL, Fitzsimmons L, Kohane IS, Scherzer CR.
Beaulieu-Jones BK, et al. Among authors: kruger mj.
medRxiv [Preprint]. 2024 Feb 18:2024.02.17.24302981. doi: 10.1101/2024.02.17.24302981.
medRxiv. 2024.
PMID: 38405736
Free PMC article.
Updated.
Preprint.